Days of Thanks / Days of Giving 2021: Week 5
December 19, 2021
December 19, 2021
For our final week of Days of Thanks / Days of Giving for 2021, our team selected nonprofits that support incarcerated people on their reentry to their community, dogs & cats that need some TLC and new homes, and efforts to free those impacted by unjust drug policy.
Michael Werner, dog-lover and Business Development Manager, picked MaxFund because of their good reputation and high scores on Charity Navigator. Currently looking for the right pet to adopt, Michael has an extra personal fondness for MaxFund and their local, high-impact operation.
MaxFund is a true no-kill animal shelter and adoption center that “gives animals, including the injured, abandoned and abused, a “second chance at life.
Staff Accountant Courtney Gomez selected a Boulder organization called Focus Reentry. The nonprofit provides mentors to men and women who have been incarcerated in the Boulder County Jail before, during, and after their release and reentry into the community. They help individuals stabilize, achieve self-sufficiency, and rebuild their lives during this challenging and critical period.
I think the work they do is so impactful and not fully recognized by most. And for a lot of the clients they work with, it’s sometimes the first time they have had a stable healthy relationship with another individual. As a former volunteer, I still keep in contact with many of the clients I worked with just to give them a positive person to relate to and hopefully provide support many of them have not had before. — Courtney Gomez
Last Prisoner Project
More about their work:
“As the United States moves away from the criminalization of cannabis, giving rise to a major new industry, there remains the fundamental injustice inflicted upon those who have suffered criminal convictions and the consequences of those convictions.
Through legal intervention, public education, and legislative advocacy, we work to redress the past and continuing harms of our country’s unjust and ineffective approach to drug policy.”